| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0002 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |